Inflammation‐induced cholestasis in cancer cachexia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Cachexia, Sarcopenia and Muscle Année : 2020

Inflammation‐induced cholestasis in cancer cachexia

Morgane M Thibaut
Martina Sboarina
  • Fonction : Auteur
Martin Roumain
  • Fonction : Auteur
Sarah A Pötgens
  • Fonction : Auteur
Audrey M Neyrinck
Florence Destrée
  • Fonction : Auteur
Justine Gillard
  • Fonction : Auteur
Isabelle A Leclercq
  • Fonction : Auteur
Guillaume Dachy
  • Fonction : Auteur
Jean‐baptiste Demoulin
  • Fonction : Auteur
Marialetizia Rastelli
Amandine Everard
  • Fonction : Auteur
Patrice D Cani
Paolo E Porporato
Audrey Loumaye
  • Fonction : Auteur
Jean‐paul Thissen
  • Fonction : Auteur
Giulio G Muccioli
Nathalie M Delzenne
Laure B Bindels
  • Fonction : Auteur
  • PersonId : 880294

Résumé

Abstract Background Cancer cachexia is a debilitating metabolic syndrome contributing to cancer death. Organs other than the muscle may contribute to the pathogenesis of cancer cachexia. This work explores new mechanisms underlying hepatic alterations in cancer cachexia. Methods We used transcriptomics to reveal the hepatic gene expression profile in the colon carcinoma 26 cachectic mouse model. We performed bile acid, tissue mRNA, histological, biochemical, and western blot analyses. Two interventional studies were performed using a neutralizing interleukin 6 antibody and a bile acid sequestrant, cholestyramine. Our findings were evaluated in a cohort of 94 colorectal cancer patients with or without cachexia (43/51). Results In colon carcinoma 26 cachectic mice, we discovered alterations in five inflammatory pathways as well as in other pathways, including bile acid metabolism, fatty acid metabolism, and xenobiotic metabolism (normalized enrichment scores of −1.97, −2.16, and −1.34, respectively; all P adj < 0.05). The hepatobiliary transport system was deeply impaired in cachectic mice, leading to increased systemic and hepatic bile acid levels (+1512 ± 511.6 pmol/mg, P = 0.01) and increased hepatic inflammatory cytokines and neutrophil recruitment to the liver of cachectic mice (+43.36 ± 16.01 neutrophils per square millimetre, P = 0.001). Adaptive mechanisms were set up to counteract this bile acid accumulation by repressing bile acid synthesis and by enhancing alternative routes of basolateral bile acid efflux. Targeting bile acids using cholestyramine reduced hepatic inflammation, without affecting the hepatobiliary transporters (e.g. tumour necrosis factor α signalling via NFκB and inflammatory response pathways, normalized enrichment scores of −1.44 and −1.36, all P adj < 0.05). Reducing interleukin 6 levels counteracted the change in expression of genes involved in the hepatobiliary transport, bile acid synthesis, and inflammation. Serum bile acid levels were increased in cachectic vs. non‐cachectic cancer patients (e.g. total bile acids, +5.409 ± 1.834 μM, P = 0.026) and were strongly correlated to systemic inflammation (taurochenodeoxycholic acid and C‐reactive protein: ρ = 0.36, P adj = 0.017). Conclusions We show alterations in bile acid metabolism and hepatobiliary secretion in cancer cachexia. In this context, we demonstrate the contribution of systemic inflammation to the impairment of the hepatobiliary transport system and the role played by bile acids in the hepatic inflammation. This work paves the way to a better understanding of the role of the liver in cancer cachexia.
Fichier principal
Vignette du fichier
JCSM-12-70.pdf (12.53 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04370790 , version 1 (03-01-2024)

Licence

Identifiants

Citer

Morgane M Thibaut, Martina Sboarina, Martin Roumain, Sarah A Pötgens, Audrey M Neyrinck, et al.. Inflammation‐induced cholestasis in cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle, 2020, 12 (1), pp.70-90. ⟨10.1002/jcsm.12652⟩. ⟨hal-04370790⟩
13 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More